US Patent Issued to Sarepta Therapeutics on Aug. 19 for "Adeno-associated virus antibodies and fragments thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,745, issued on Aug. 19, was assigned to Sarepta Therapeutics Inc. (Cambridge, Mass.).

"Adeno-associated virus antibodies and fragments thereof" was invented by Sohrab Khan (Cambridge, Mass.), Danielle Griffin (Cambridge, Mass.) and Louise Rodino-Klapac (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to an isolated anti-AAV (adeno-associated virus) antibody or an antigen-binding fragment thereof capable of specifically binding an epitope of AAVrh74 capsid protein and uses thereof."

The patent was filed on June 15, 2021, under Application No. 17/348,356.

*For further information, including images, char...